In clinical trials, patients with severe FSH and LH deficiency were defined by an endogenous serum LH level < 1.2 IU/ l as measured in a central laboratory.
Kliinilistes uuringutes määratleti FSH ja LH raske defitsiitsusega naiste hulka patsiendid, kelle LH tase vereseerumis oli < 1, 2 RÜ/ l, määratuna kesklaboratooriumis.